Percutaneous surgical lead body with directed stimulation

• US 6,587,733 B1
• Filed: 02/08/2000
• Issued: 07/01/2003
• Est. Priority Date: 02/08/2000
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Cross, Thomas E. Jr., Redko, Vladimir, Alo, Kenneth M.
• Primary Examiner(s): Schaetzle, Kennedy
• Application Number:
  US09/500,201
• Time in Patent Office: 1,239 Days
• Field of Search: 604/116, 604/117, 604/121-123, 604/148, 600/373, 600/377, 600/393
• US Class Current: 607/116
• CPC Class Codes: A61B 2562/227 Sensors with electrical connectors
• CPC Class Codes: A61B 5/24 Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
• CPC Class Codes: A61B 5/4041 Evaluating nerves condition
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: H01R 13/025 formed by the conductors of a cable end
• CPC Class Codes: H01R 2201/12 for medicine and surgery

Abstract

There is disclosed a surgical lead comprising two percutaneous lead bodies bonded together. The inventive lead body results in the equivalent of a surgical lead body with columns of electrodes either adjacent to or offset from each other. A bridge of urethane material is used to bond together the percutaneous lead bodies and still provide suitable flexibility of the lead. The surface of the electrodes may be coated, in part, with a suitable non-conductive coating to effectively direct the electrical stimulation signals toward the targeted stimulation area. Significantly, the resulting lead is sized to fit within a needle having a similar cross-section, thereby permitting the percutaneous implantation of the inventive lead.

Claims

1. A controlled orientation stimulation lead for percutaneous implantation, comprising:

a first lead body having at least one electrode extending around the periphery of the first lead body;

a second lead body attached to the first lead body, the second lead body having at least one electrode extending around the periphery of the second lead body;

a mask applied to a portion of the at least one electrode of either the first or second lead body;

a first lead side formed from the first lead body attached to the second lead body, the first lead side having a first stimulation pattern; and

a second lead side opposite the first lead side having a second stimulation pattern that is orientatable to a preselected stimulation site.

2. The controlled orientation stimulation lead as in claim 1 wherein at least one electrode on the first lead body is substantially adjacent to at least one electrode on the second lead body.

3. The controlled orientation stimulation lead as in claim 1 wherein the mask configures the stimulation pattern of the electrode.

4. The controlled orientation stimulation lead as in claim 1 wherein the mask electrically insulates at least one electrode on a first lead body from at least one electrode on a second lead body.

5. The controlled orientation stimulation lead as in claim 1 wherein stimulation lead stiffness is controlled by attachments between the first lead body and the second lead body.

6. An implantable medical lead for electrical stimulation at a targeted stimulation area, the medical lead defining a first and second side, comprising:

a first percutaneous lead body having at least one electrode,

a second percutaneous lead body bonded to the first percutaneous lead body, the second percutaneous lead body also having at least one electrode, and

a non-conductive coating applied to at least a portion of either of the first or second sides of the medical lead,

whereby the medical lead may be percutaneously implanted at the targeted stimulation area.

7. The implantable medical lead of claim 6 wherein the first and second percutaneous lead bodies are bonded together by a urethane material.

8. The implantable medical lead of claim 7 wherein the bonding of the first and second percutaneous lead bodies is effected by multiple bridges of the urethane material.

9. The implantable medical lead of claim 6 wherein the at least one electrode of the first percutaneous lead body is positioned off-set to the at least one electrode of the second percutaneous lead body.

10. The implantable medical lead of claim 6 wherein the first and second percutaneous lead bodies are bonded together by a continuous urethane bridge.

11. The implantable medical lead of claim 6 wherein the non-conductive coating is polyurethane.

12. A method of forming a surgical lead body comprising the steps of:

providing a first percutaneous lead body having at least one electrode,

providing a second percutaneous lead body having at least one electrode,

bonding the first percutaneous lead body to the second percutaneous lead body to form the surgical lead body, the surgical lead body defining a first side and a second side, and

coating either of the first or second side of the surgical lead body with a urethane material,

whereby the surgical lead body may be percutaneously implanted.

13. The method of claim 12 wherein the bonding of the first and second percutaneous lead bodies is accomplished by a plurality of urethane bridges molded to the percutaneous lead bodies.

14. The method of claim 12 further comprising the step of positioning the plurality of electrodes on the first percutaneous lead body adjacent to the plurality of electrodes on the second percutaneous lead body prior to bonding.

15. A method of implanting a surgical lead body comprising the steps of:

providing a first percutaneous lead body having at least one electrode,

providing a second percutaneous lead body having at least one electrode,

bonding the first percutaneous lead body to the second percutaneous lead body to form the surgical lead body, the surgical lead body defining a first side and a second side,

coating either of the first or second side of the surgical lead body with a urethane material,

inserting a needle having an opening to a targeted stimulation area,

inserting the surgical lead body through the opening of the needle to the targeted stimulation area, and

removing the needle from the targeted stimulation area.

16. The method of claim 15 further comprising the step of inserting the surgical lead body such that the side other than the first or second side having the coating is adjacent to the targeted stimulation area.

17. The method of claim 15 further comprising the step of positioning the at least one electrode on the first and second percutaneous lead bodies off-set to each other prior to bonding.

18. The method of claim 15 wherein the bonding of the first and second percutaneous lead bodies is accomplished by a plurality of urethane bridges molded to the percutaneous lead bodies.

19. The method of claim 15 further comprising the step of positioning the at least one electrode on the first and second percutaneous lead bodies adjacent to each other prior to bonding.

20. An implantable medical lead for electrical stimulation at a targeted stimulation area, the medical lead defining a first and second side, comprising:

a first lead body having at least one electrode,

a second lead body bonded at multiple locations to the first lead body, the second lead body also having at least one electrode, and

a non-conductive coating applied to at least a portion of either of the first or second sides of the medical lead,

whereby the medical lead may be percutaneously implanted at the targeted stimulation area.

21. The implantable medical lead of claim 20 wherein the first and second lead bodies are bonded together by a urethane material.

22. The implantable medical lead of claim 21 wherein the at least one electrode of the first lead body is positioned off-set to the at least one electrode of the second lead body.

23. The implantable medical lead of claim 20 wherein the multiple bonding of the first and second lead bodies is effected by multiple bridges of the urethane material.

24. The implantable medical lead of claim 20 wherein the non-conductive coating is polyurethane.